What is it about?
A type of medications used to treat type 2 diabetes and obesity, GLP-1 receptor agonists, may also help patients with alcohol use diorder decrease their drinking. Here we help clarify how this medication works on the brain.
Featured Image
Photo by Sara Ben Aziza on Unsplash
Why is it important?
Alcohol use disorder is a considerable global public health issue affecting over 14 million in the USA alone. While available treatments can be effective in some patients, the disease remains severely undertreated and new, effective medications are urgently needed.
Read the Original
This page is a summary of: Glucagon-like peptide-1 receptors in nucleus accumbens, ventral hippocampus, and lateral septum reduce alcohol reinforcement in mice., Experimental and Clinical Psychopharmacology, December 2022, American Psychological Association (APA),
DOI: 10.1037/pha0000620.
You can read the full text:
Contributors
The following have contributed to this page
